Uffelmann, Emil http://orcid.org/0000-0002-0682-7880
Huang, Qin Qin http://orcid.org/0000-0003-3073-717X
Munung, Nchangwi Syntia http://orcid.org/0000-0003-1498-3602
de Vries, Jantina
Okada, Yukinori http://orcid.org/0000-0002-0311-8472
Martin, Alicia R.
Martin, Hilary C.
Lappalainen, Tuuli
Posthuma, Danielle http://orcid.org/0000-0001-7582-2365
Article History
Accepted: 13 July 2021
First Online: 26 August 2021
Competing interests
: T.L. is an adviser to Goldfinch Bio, Variant Bio and GSK, and has equity in Variant Bio. The other authors declare no competing interests.
Free to read: This content has been made available to all.